UBS
-
US drug maker's stake in Haleon set to fall to 24%
-
Demand for domestic covered bonds drives strong outcomes for issuers
-
Europe's biggest IPO of the year so far gains traction with investors
-
Strong demand allows grid operator to tighten price and land inside fair value
-
French bank aims for size over price, but lands in line with euro funding sources
-
Over €12.5bn of orders pledged for rare and tightly priced covered bonds
-
Swiss bank expected to offer a pick-up over other non-eurozone names
-
Agricole issued early in January, but found the market in better health on its second visit
-
Borrowers benefit from scarcity value and lack of competing supply
-
-
◆ French bank raises €500m from a 12 year non-call seven tier two social bond ◆ Strong demand for FIG capital pushes final book to €5.6bn ◆ UBS returns to Singapore with fresh AT1
-
UK lender prints largest single tranche covered bond from a foreign issuer since last August